Avid Bioservices, Inc. (CDMO)
Market Cap | 785.47M |
Revenue (ttm) | 150.45M |
Net Income (ttm) | -152.05M |
Shares Out | 63.96M |
EPS (ttm) | -2.39 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 141,842 |
Open | 12.29 |
Previous Close | 12.30 |
Day's Range | 12.28 - 12.32 |
52-Week Range | 5.65 - 12.48 |
Beta | 1.41 |
Analysts | Hold |
Price Target | 12.25 (-0.24%) |
Earnings Date | Dec 10, 2024 |
About CDMO
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line developme... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for CDMO stock is "Hold." The 12-month stock price forecast is $12.25, which is a decrease of -0.24% from the latest price.
News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / December 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. ("Avid") (NASDAQ:CDMO) and GHO Capital Partners and A...
The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Avid Bioservices Inc For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
Avid Bioservices Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Avid Bioservices Inc. For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
TUSTIN, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) wo...
Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Stockholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / December 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. ("Avid") (NASDAQ:CDMO) and GHO Capital Partners and A...
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Avid Bioservices Inc For Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Avid Bioservices Inc For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
Bronstein, Gewirtz & Grossman, LLC Encourages Avid Bioservices, Inc. (CDMO) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESSWIRE / December 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. ("Avid") (NASDAQ:CDMO) and GHO Capital Partners and A...
The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Avid Bioservices Inc For Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
Avid Bioservices, Inc. Is Being Investigated For Securities Related Infractions And Affected Investors Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Avid Bioservices Inc For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avid Bioservices, Inc. (CDMO) And Encourages Investors to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / December 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. ("Avid") (NASDAQ:CDMO) and GHO Capital Partners and A...
Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservi...
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient liv...
The Schall Law Firm Encourages Stockholder Contributions To An Inquiry Into Avid Bioservices Inc's Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservic...
Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Reach Out To The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservic...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avid Bioservices, Inc. (CDMO) And Encourages Stockholders to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / December 8, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. ("Avid") (NASDAQ:CDMO) and GHO Capital Partners and Am...
The Schall Law Firm Urges Public Participation In An Inquiry Into Avid Bioservices Inc's Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservic...
Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Assist The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservic...
The Schall Law Firm Urges Stockholders To Take Part In An Inquiry Into Avid Bioservices Inc's Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservic...
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / December 5, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. ("Avid") (NASDAQ:CDMO) and GHO Capital Partners and Am...
The Schall Law Firm Urges Shareholders With Losses To Take Part In An Inquiry Of Avid Bioservices Inc For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservic...